WallabyPhenox Restructures Debt and Accelerates Global GrowthIRVINE, Calif., March 18, 2026 (GLOBE NEWSWIRE) -- WallabyPhenox, a global neurovascular medical technology company, today announced the successful completion of a significant financing round aimed at strengthening its financial foundation. The proceeds will be utilized to fully restructure the company’s capital framework and accelerate its long-term global growth initiatives.
